Hikma Pharmaceutical(HKMPF)

Description: Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment manufactures, markets, and sells generic injectable products for therapeutic categories, including anti-infective, anaesthetic, central nervous system (CNS), oncology, and pain management, as well as controlled substances and cardiovascular products. The Generics segment develops and sells approximately 100 oral and other non-injectable generic products for oncology and pain management, as well as respiratory, nasal spray, suspension, liquid solution, and high-containment areas. The Branded segment develops, manufactures, and markets branded generics and in-licensed products, such as anti-infective products, as well as chronic therapeutic categories comprising cardiovascular, diabetes, CNS, and oncology products. The company also manufactures plastic specialized medicinal sterile containers and APIs; and conducts bio-equivalency studies. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

---

Keywords: Pain Diabetes Pain Management Suspension Dosage Form Kma Licensed Products Osage Cardiovascular Products Nasal Spray Oncology Products Generic Products Injectable Products Anti Infective Products Generic Injectable Products Hikma Pharmaceuticals

---

Home Page: www.hikma.com

1 New Burlington Place
London, W1S 2HR
United Kingdom
Phone: 44 20 7399 2760

---

Officers

Exchange: PINK

Country: US

Currency: US Dollar ($)